Home | Contact us | About Us | Trials | Principal Investigators | Our Collaborators | Download Forms

Diabetes Mellitus

Protocol H7U-MC-IDAU A Phase 3, Open-Label, Parallel Group Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder(HIIP) Compared to Preprandial Injectable Insulin in Insulin-Naive Patients with Type 2 Diabetes Mellitus.

____________________________________________________________________________________________

The Durability of Twice-Daily Insulin Lispro Low Mixture Compared to Once-Daily Insulance Glargine when added to Existing Oral Therapy in Patients with Type 2 Diabetes and inadequate Glycemic Control.

____________________________________________________________________________________________

Impact of a Self-Adjusted Titration Guideline in Subjects with Type 2 Diabetes Mellitus: A 6-Month, Multicenter, Open-Label, Randomized, Parallel-Group, treat-to-Target of the Efficacy and Safety of Levemir (R) (insulin detemir [rDNA origin] injection).

____________________________________________________________________________________________

   A 24 weeks multi center double blind study comparing Lantus (Basal Insulin Glargine) with 75/25 (NPH. Humalog). 

____________________________________________________________________________________________

A 48 weeks double blind multi center study to see the effects of HRT in postmenopausal women in terms of Bone Mineral Density.

____________________________________________________________________________________________

 A double -blind placebo-controlled dose finding trial to evaluate the efficacy and safety of R 149524 in diabetic subjects with symptoms of Gastroparesis.

____________________________________________________________________________________________

 A Randomized Comparator Controlled Double Blind Study of the liver Safety of Pioglitazone HCL versus Glyburide with Metformin and Insulin as part of step therapy in subjects with Type 2 (Non-Insulin Dependent) Diabetes.

____________________________________________________________________________________________

Multi center, randomized, open label, cross-over trial in Insulin requiring Type 1 subjects with Diabetes; Preference and frequency of Blood Glucose Monitoring Comparison with MS 231 and Vial/ Syringe/ Separate Meter.

____________________________________________________________________________________________

A 24 weeks multi center, double-blind, randomized, parallel-group, fixed dose study to prospectively evaluate the safety, efficiency and tolerability of oral Nateglinide plus Rosiglitazone combination therapy compared to oral Rosiglitazone mono therapy in patients with Type 2 diabetes mellitus inadequately controlled with prior Rosiglitazone mono therapy and diet & exercise.

____________________________________________________________________________________________

A multi center, double blind, randomized, parallel-group, dose-ranging Study to Assess the Efficacy, Safety and Tolerability of LAF237 different doses compared to placebo in patients with type II Diabetes.

____________________________________________________________________________________________

A study to evaluate the impact of adjunct TZD therapy on blood lipids and glycernic control in patients with type 2 diabetes following treatment with biguanide and/or sulfonylurea therapy.

____________________________________________________________________________________________

A double blind, randomized, placebo and active controlled safety and efficacy study of Bazedoxifene/ conjugated estrogens combination in postmenopausal women.

____________________________________________________________________________________________

Fracture incidence reduction and safety of TSE-424 (Bazedoxifene and Acetate) compared to placebo and Raloxifene in osteoporotic postmenopausal women.

____________________________________________________________________________________________

An Open-Label Study to Evaluate the Efficacy and Safety of Tadalafil Administered “On Demand” to Men of Various   Populations with Erectile Dysfunction.

____________________________________________________________________________________________

A double-blind,randomized multicenter study to assess the efficacy and safety of tegaserod and placebo in female patients with Dyspepsia.

____________________________________________________________________________________________

A 52 wk randomized,Double-Blind,Parallel group Multi-Center Study to evaluate the Efficacy,Safety and Tolerability of Tesaglitazar Therapy in Type 11 Diabetics.

____________________________________________________________________________________________

The Durability of Twice–DailyInsulin Lispro Low Mixture Compared to Once-Daily Insulin Glargine when added to existing oral therapy to Type II Diabetics with inadequate Glycemic Control,F3Z-US-IOOV (1).2006.

____________________________________________________________________________________________

A Phase III,Open Label,Parallel Group Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Insulin–Naïve Patients with Type II Diabetes,the H7U-MC-IDAU Protocol.2006.

HOME
CONTACT US
ABOUT US
TRIALS
PRINCIPAL INVESTIGATORS
Our Collaborators